Constipation Treatment Market: A Common Condition With a...

Constipation Treatment Market: A Common Condition With a Surprisingly Large Commercial Footprint

Postado 2026-10-28 05:40:34

Constipation is one of the most common gastrointestinal complaints worldwide — and one of the most undertreated. Affecting roughly 20% of the population at some point, with prevalence reaching 30–40% among older adults, it drives enormous demand for over-the-counter and prescription therapies. As awareness of digestive health grows, the constipation treatment market continues to expand steadily.

The market spans over-the-counter medications, prescription drugs, dietary supplements, and probiotics, in tablets, liquids, powders, and suppositories, distributed through pharmacies, hospital pharmacies, and online channels. According to constipation treatment market research, the market was valued at approximately USD 5.39 billion in 2024 and is projected to reach USD 8 billion by 2035, growing at a CAGR of 3.66%. Over-the-counter medications hold the largest share at around 56%, while prescription medications are the fastest-growing segment. North America leads with roughly 45% share, while Asia-Pacific is expected to grow fastest.

Innovation is focused on novel mechanisms — including guanylate cyclase-C agonists — and natural remedies. Recent industry activity includes FDA approvals for chronic constipation therapies, expanded partnerships to co-promote leading prescription treatments, and acquisitions of microbiome-focused startups.

Challenges include price competition in OTC segments, underdiagnosis, and the need for better long-term therapies. Yet the fundamentals are strong: ageing populations, sedentary lifestyles, and rising digestive health awareness. The market is expected to grow steadily.

Constipation Treatment Market: A Common Condition With a Surprisingly Large Commercial Footprint

People Also Ask